What is DoseMe?
DoseMe operates at the intersection of healthcare technology and clinical decision support, providing a sophisticated digital platform known as DoseMeRx. By leveraging patient-specific clinical data alongside advanced pharmacokinetic and pharmacodynamic modeling, the company enables clinicians to move beyond population-based averages. This shift toward individualized dosing is critical for enhancing medication safety and therapeutic efficacy. The platform serves a diverse array of healthcare environments, including hospitals and pharmacies, by synthesizing laboratory results and pharmacological models into actionable, personalized dosing recommendations. By optimizing therapy at the individual level, DoseMe addresses the inherent risks associated with standardized dosing protocols, thereby establishing itself as a vital component of modern evidence-based medicine.
How much funding has DoseMe raised?
DoseMe has raised a total of $3.1M across 2 funding rounds:
Angel/Seed
$500K
Series A
$2.6M
Angel/Seed (2014): $500K, investors not publicly disclosed
Series A (2016): $2.6M, investors not publicly disclosed
Key Investors in DoseMe
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for DoseMe?
With the recent influx of capital, DoseMe is well-positioned to scale its operations and expand the reach of its model-informed precision dosing system. The strategic focus will likely shift toward deepening the integration of its software within existing electronic health record systems, thereby reducing friction for clinicians and increasing adoption rates. As the healthcare industry continues to prioritize patient safety and cost-effective treatment outcomes, DoseMe is poised to capitalize on the increasing demand for digital health solutions that offer measurable clinical improvements. Future growth will likely involve expanding the library of supported medications and enhancing the predictive accuracy of its modeling algorithms to maintain a competitive edge in the precision medicine landscape.
See full DoseMe company page
